Physician profile
Marcus Evans
NPI 1922641299
$1,342.94
in general payments reported to CMS, 2019-2025
13 companies · $181 in 2025
The $181 reported for 2025 was less than what a typical Gerontology (Nurse Practitioner) provider received nationally (typical 2025 total: $180).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $43.83 · 2022: $511 · 2023: $548 · 2024: $59.43 · 2025: $181.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $788.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $788.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $230.03 | 2022-2025 | Lifevest |
| Amgen INC. | $211.89 | 2022-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $182.27 | 2022-2024 | |
| Edwards Lifesciences Corporation | $146.43 | 2023 | Edwards Sapien 3 Ultra Transcatheter Heart Valve |
| Pfizer INC. | $133.33 | 2021-2025 | |
| Atricure, INC. | $129.21 | 2022 | |
| Novo Nordisk INC | $117.76 | 2022-2023 | Ozempic, Rybelsus |
| Janssen Pharmaceuticals, INC | $68.69 | 2021-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $64.20 | 2022-2025 | Verquvo |
| Chiesi USA, INC. | $15.88 | 2024 | Cleviprex, Kengreal |
| Philips North America LLC | $15.86 | 2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $14.52 | 2022 | |
| Astrazeneca Pharmaceuticals Lp | $12.87 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marcus Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.